These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12506021)

  • 1. Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG.
    Song S; Crow AR; Freedman J; Lazarus AH
    Blood; 2003 May; 101(9):3708-13. PubMed ID: 12506021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?
    Siragam V; Brinc D; Crow AR; Song S; Freedman J; Lazarus AH
    J Clin Invest; 2005 Jan; 115(1):155-60. PubMed ID: 15630455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIg.
    Song S; Crow AR; Siragam V; Freedman J; Lazarus AH
    Blood; 2005 Feb; 105(4):1546-8. PubMed ID: 15479722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fcγ receptor inhibition.
    Norris PAA; Kaur G; Khan R; Zhu G; Ni H; Lazarus AH
    Blood; 2021 Apr; 137(15):2114-2124. PubMed ID: 33662988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia.
    Tremblay T; Paré I; Bazin R
    Transfusion; 2013 Feb; 53(2):261-9. PubMed ID: 22670706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody-mediated amelioration of murine immune thrombocytopenia.
    Crow AR; Suppa SJ; Chen X; Mott PJ; Lazarus AH
    Blood; 2011 Dec; 118(24):6403-6. PubMed ID: 22001393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia.
    Crow AR; Song S; Siragam V; Lazarus AH
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):710-3. PubMed ID: 16933274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption.
    Crow AR; Amash A; Lazarus AH
    Transfusion; 2015 Jun; 55(6 Pt 2):1492-500. PubMed ID: 25496771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of immune thrombocytopenia in mice by cross-linking human immunoglobulin G with a high-affinity monoclonal antibody.
    Bazin R; Lemieux R; Tremblay T
    Br J Haematol; 2006 Oct; 135(1):97-100. PubMed ID: 16925577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic/pharmacodynamic modeling of the effects of intravenous immunoglobulin on the disposition of antiplatelet antibodies in a rat model of immune thrombocytopenia.
    Hansen RJ; Balthasar JP
    J Pharm Sci; 2003 Jun; 92(6):1206-15. PubMed ID: 12761810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin and anti-D in idiopathic thrombocytopenic purpura (ITP): mechanisms of action.
    Lazarus AH; Freedman J; Semple JW
    Transfus Sci; 1998 Sep; 19(3):289-94. PubMed ID: 10351141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IVIg inhibits reticuloendothelial system function and ameliorates murine passive-immune thrombocytopenia independent of anti-idiotype reactivity.
    Crow AR; Song S; Semple JW; Freedman J; Lazarus AH
    Br J Haematol; 2001 Dec; 115(3):679-86. PubMed ID: 11736954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of murine immune thrombocytopenia by CD44 antibodies: a potential therapy for ITP?
    Crow AR; Song S; Suppa SJ; Ma S; Reilly MP; Andre P; McKenzie SE; Lazarus AH
    Blood; 2011 Jan; 117(3):971-4. PubMed ID: 21045192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Fcgamma receptors in the pathogenesis and treatment of idiopathic thrombocytopenic purpura.
    Crow AR; Lazarus AH
    J Pediatr Hematol Oncol; 2003 Dec; 25 Suppl 1():S14-8. PubMed ID: 14668633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of platelet phagocytosis as an in vitro predictor for therapeutic potential of RBC antibodies in murine ITP.
    Khan R; Menard M; Jen CC; Chen X; Norris PAA; Lazarus AH
    Blood; 2020 Jun; 135(26):2420-2424. PubMed ID: 32374819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of IVIG and anti-D in ITP.
    Lazarus AH; Crow AR
    Transfus Apher Sci; 2003 Jun; 28(3):249-55. PubMed ID: 12725951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of murine passive immune thrombocytopenia by IVIg and a therapeutic monoclonal CD44 antibody does not require the Myd88 signaling pathway.
    Crow AR; Yu H; Han D; Lazarus AH
    PLoS One; 2013; 8(8):e71882. PubMed ID: 23940791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells.
    Bazin R; Lemieux R; Tremblay T; St-Amour I
    Br J Haematol; 2004 Oct; 127(1):90-6. PubMed ID: 15384982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic/pharmacodynamic modeling of IVIG effects in a murine model of immune thrombocytopenia.
    Deng R; Balthasar JP
    J Pharm Sci; 2007 Jun; 96(6):1625-37. PubMed ID: 17238194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia.
    Teeling JL; Jansen-Hendriks T; Kuijpers TW; de Haas M; van de Winkel JG; Hack CE; Bleeker WK
    Blood; 2001 Aug; 98(4):1095-9. PubMed ID: 11493456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.